Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

renal cell carcinoma

  • You have access
    Investigating miRNA-related Pathways Contributing to Kidney Cancer Pathogenesis
    PETER YOUSEF, RANIA IBRAHIM, CARL BOULOS, ZIYAD KHATAB, MARIA PASIC and ADRIANA KRIZOVA
    Anticancer Research May 2022, 42 (5) 2355-2362; DOI: https://doi.org/10.21873/anticanres.15714
  • You have access
    Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
    SUGURU SHIROTAKE, YU MIYAMA, YASUTAKA BABA, HIROYUKI TAJIMA, YOSHITAKA OKADA, KEN NAKAZAWA, YOKO USAMI, MASANORI YASUDA, DAISUKE IGARASHI, GO KANEKO, KENT KANAO, MASAFUMI OYAMA and KOSHIRO NISHIMOTO
    Anticancer Research May 2022, 42 (5) 2727-2735; DOI: https://doi.org/10.21873/anticanres.15751
  • You have access
    Tumor Size Significantly Affects Prognosis in Pathological T3a Renal Cell Carcinoma
    GU-SHUN LAI, JIAN-RI LI, SHIAN-SHIANG WANG, CHUAN-SHU CHEN, CHUN-KUANG YANG, SHENG-CHUN HUNG, CHEN-LI CHENG, YEN-CHUAN OU and KUN-YUAN CHIU
    Anticancer Research April 2022, 42 (4) 2185-2191; DOI: https://doi.org/10.21873/anticanres.15701
  • You have access
    SBRT in Localized Renal Carcinoma: A Review of the Literature
    CAROLINA DE LA PINTA, RAQUEL GARCÍA LATORRE and RAQUEL FUENTES
    Anticancer Research February 2022, 42 (2) 667-674; DOI: https://doi.org/10.21873/anticanres.15525
  • You have access
    Prognostic Value of Copine 1 in Patients With Renal Cell Carcinoma
    IMAN M. TALAAT, EMAN ABU-GHARBIEH, AMAL HUSSEIN, MAHMOOD HACHIM, ISRAA SOBHY, MOHAMED ELADL and WASEEM EL-HUNEIDI
    Anticancer Research January 2022, 42 (1) 355-362; DOI: https://doi.org/10.21873/anticanres.15493
  • You have access
    A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell Carcinoma
    RENPEI KATO, TAKAHIRO KOJIMA, TOMOKAZU SAZUKA, HAYATO YAMAMOTO, SHOHEI FUKUDA, KAZUTOSHI YAMANA, YUSUKE SUGINO, SHUZO HAMAMOTO, NOBORU NAKAIGAWA, KOKI KABU, HIROSHI MURAKAMI and WATARU OBARA
    Anticancer Research December 2021, 41 (12) 6199-6209; DOI: https://doi.org/10.21873/anticanres.15439
  • You have access
    Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    TAIGO KATO, AKIRA NAGAHARA, NORIHIKO KAWAMURA, WATARU NAKATA, TETSUJI SODA, KYOSUKE MATSUZAKI, KOJI HATANO, ATSUNARI KAWASHIMA, TAKESHI UJIKE, RYOICHI IMAMURA, KENSAKU NISHIMURA, SHINGO TAKADA, MASAO TSUJIHATA, SEIJI YAMAGUCHI, TETSUYA TAKAO, YASUTOMO NAKAI, MASASHI NAKAYAMA, NORIO NONOMURA and MOTOHIDE UEMURA
    Anticancer Research November 2021, 41 (11) 5811-5816; DOI: https://doi.org/10.21873/anticanres.15398
  • You have access
    CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
    YOHEI SEKINO, KENSHIRO TAKEMOTO, DAIKI MURATA, TAKASHI BABASAKI, KOHEI KOBATAKE, HIROYUKI KITANO, KENICHIRO IKEDA, KEISUKE GOTO, SHOGO INOUE, TETSUTARO HAYASHI, DAIKI TANIYAMA, MASANOBU SHIGETA, KAZUYA KURAOKA, KOJI MITA, MAYUMI KANEKO, KAZUHIRO SENTANI, NAOHIDE OUE and JUN TEISHIMA
    Anticancer Research October 2021, 41 (10) 4875-4883; DOI: https://doi.org/10.21873/anticanres.15301
  • You have access
    Clinical Significance of 18F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma
    HIRONORI BETSUNOH, SETSU SAKAMOTO, YASUSHI KAJI, AKINORI NUKUI, MINORU KOBAYASHI, MASAHIRO YASHI, KEITARO HAYASHI, NAOHIKO ANZAI and TAKAO KAMAI
    Anticancer Research October 2021, 41 (10) 5179-5188; DOI: https://doi.org/10.21873/anticanres.15336
  • You have access
    P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
    YOHEI SEKINO, KENSHIRO TAKEMOTO, DAIKI MURATA, TAKASHI BABASAKI, KOHEI KOBATAKE, HIROYUKI KITANO, KENICHIRO IKEDA, KEISUKE GOTO, SHOGO INOUE, TETSUTARO HAYASHI, DAIKI TANIYAMA, MASANOBU SHIGETA, KAZUYA KURAOKA, KOJI MITA, MAYUMI KANEKO, KAZUHIRO SENTANI, NAOHIDE OUE and JUN TEISHIMA
    Anticancer Research September 2021, 41 (9) 4287-4294; DOI: https://doi.org/10.21873/anticanres.15233

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 10
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire